Greg Kennedy, BSc (Hons) PhD

JAD profile

Affiliation(s): 

Center for Human Psychopharmacology; Swinburne University

Lab URL: 

http://www.swinburne.edu.au/lss/chp/

ORCID URL: 

https://orcid.org/0000-0002-2254-046

Areas of Interest: 

cognitive aging, exercise, fitness, Alzheimer disease, vascular and cognitive health, biomarkers of cognitive decline

Biography & Research: 

Greg Kennedy is the winner of the 2018 Alzheimer Award for his paper "How Does Exercise Reduce the Rate of Age-Associated Cognitive Decline? A Review of Potential Mechanisms", which was voted by the associate editors as best article published in the Journal of Alzheimer's Disease from the previous year He received his undergraduate degree in Psychology and Psychophysiology in 2010 at Swinburne University of Technology. He then completed a first-class Honours degree in Psychology in 2012, investigating the relationship between cognitive aging and cerebrovascular functioning, before joining the Centre for Human Psychopharmacology at Swinburne University of Technology, where he completed his PhD working with Professors Andrew Pipingas, Andrew Scholey and Denny Meyer. His research has included the effects of diet and nutrients, such as cocoa flavanols and polyphenols, on cognition and vascular health. However his primary focus as an early career researcher is on exercise and fitness as a way to attenuate the rate of age-related cognitive decline in older people, and researching the associated underlying mediating mechanisms. Greg is currently a postdoctoral researcher and trial manager for the MedWalk clinical trial. This study is investigating the potential to preserve cognition and delay the onset of dementia in older people, through a combined diet and exercise intervention program - with the use of integrated MI-CBT to support implementation and adherence.